ArriVent BioPharma, Inc. (AVBP) vs MiniMed Group, Inc. (MMEDV)
A side-by-side comparison of ArriVent BioPharma, Inc. and MiniMed Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVBP
ArriVent BioPharma, Inc.
$14.80HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
MMEDV
MiniMed Group, Inc.
$20.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AVBP vs MMEDV
growth of $100 · dividends reinvested · last 1yAVBP +0.7% (+0.7%/yr)MMEDV +7.0% (+7.0%/yr)MMEDV compounded faster over this window
AVBP MMEDV
Metrics side by side
Total return (annualized)
| Metric | AVBP | MMEDV |
|---|---|---|
| Total return (1Y) | 43.20% | N/A |
MMEDV is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.